drugset

drugset / Trial / NCT05507983

Tranexamic Acid During Excisional Burn Surgery

NCT05507983 ↗

Phase 3 Unknown 96 enrolled Maasstad Hospital Association of Dutch Burn Centres · collab Martini Hospital Groningen · collab Red Cross Hospital Beverwijk · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to access the efficacy of the drug tranexamic acid in reducing blood loss during burn excision surgery.

Timeline

Start: 2021-12-01
Primary completion: 2025-01-01
Completion: 2025-04-01

Publications

Gigengack RK, Slob J, Vries AM, Bosma E, Loer SA, Koopman JSHA, van der Vlies CH. Efficacy of tranexamic acid versus placebo in reducing blood loss during burn excisional surgery: a multi-center, double-blind, parallel, randomized placebo-controlled clinical trial (TRANEX). Trials. 2024 Aug 2;25(1):520. doi: 10.1186/s13063-024-08332-1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tranexamic Acid	Small molecule	1000 mg	—
Subject	Tranexamic Acid	Small molecule	1500 mg	—

Indications

No indication recorded.